Skip to main content
. 2018 Jun 1;7(2):38–47.

Figure 3.

Figure 3

Graphic representation that suggest the use of the best Stem Cell choice as defined by cell surface markers and source to specific tissue differentiation. The figure demonstrates that CD133+ cells obtained from blood represent the best option for differentiation protocols aimed at neurodegenerative disorders, and CD271+ cells from either source (blood or fat tissue) to protocols for muscle regeneration.